Activity
-
#NovoNordisk is feeling the heat of increased competition from #EliLilly in the lucrative #weightlossdrug market, as the Danish drugmaker reported…
#NovoNordisk is feeling the heat of increased competition from #EliLilly in the lucrative #weightlossdrug market, as the Danish drugmaker reported…
Shared by Greg Slabodkin
-
The #2024election season is well underway with #campaigncontributions pouring in from #politicalactioncommittees and individuals with ties to the…
The #2024election season is well underway with #campaigncontributions pouring in from #politicalactioncommittees and individuals with ties to the…
Shared by Greg Slabodkin
-
#CRISPR is going big by getting small. Ultra-compact systems, which are in some cases one-third the size of #Cas9, are being designed to be more…
#CRISPR is going big by getting small. Ultra-compact systems, which are in some cases one-third the size of #Cas9, are being designed to be more…
Shared by Greg Slabodkin
More activity by Greg
-
It's a bad week for #vaccine makers, not just those in the #COVID19 business but for #respiratorysyncytialvirus and other #vaccines. GSK, Moderna and…
It's a bad week for #vaccine makers, not just those in the #COVID19 business but for #respiratorysyncytialvirus and other #vaccines. GSK, Moderna and…
Shared by Greg Slabodkin
-
Q2 #biopharma earnings season is in full swing and the #InflationReductionAct’s #Medicare Drug Price Negotiation Program has been on the minds of…
Q2 #biopharma earnings season is in full swing and the #InflationReductionAct’s #Medicare Drug Price Negotiation Program has been on the minds of…
Shared by Greg Slabodkin
-
#BigPharma and #pharmacybenefitmanagers are both at fault for high #prescriptiondrugprices and the finger-pointing/blame game hasn't gotten us any…
#BigPharma and #pharmacybenefitmanagers are both at fault for high #prescriptiondrugprices and the finger-pointing/blame game hasn't gotten us any…
Shared by Greg Slabodkin
-
With a population of about 1.4 billion, #China is a lucrative market for #weightlossdrugs. The country recently approved #NovoNordisk's Wegovy…
With a population of about 1.4 billion, #China is a lucrative market for #weightlossdrugs. The country recently approved #NovoNordisk's Wegovy…
Shared by Greg Slabodkin
-
Despite a high level of efficacy in delivering cytotoxic payloads directly to #tumorcells, drug developers are looking to build on the success of…
Despite a high level of efficacy in delivering cytotoxic payloads directly to #tumorcells, drug developers are looking to build on the success of…
Shared by Greg Slabodkin
-
#Psychedelic drug developers got a wake-up call when an #FDA advisory committee recommended against approving Lykos' #MDMA-assisted therapy to treat…
#Psychedelic drug developers got a wake-up call when an #FDA advisory committee recommended against approving Lykos' #MDMA-assisted therapy to treat…
Shared by Greg Slabodkin
-
While effective treatments for #depression exist, many patients are still left behind by current drugs. With the global depression market projected…
While effective treatments for #depression exist, many patients are still left behind by current drugs. With the global depression market projected…
Shared by Greg Slabodkin
-
#AbbVie and #Merck-#DaiichiSankyo were hit this week with #CompleteResponseLetters from the #FDA, rejecting their #drugapplications due to issues…
#AbbVie and #Merck-#DaiichiSankyo were hit this week with #CompleteResponseLetters from the #FDA, rejecting their #drugapplications due to issues…
Shared by Greg Slabodkin
-
#BigPharma companies like BMS, J&J and Pfizer are facing #patentcliffs that will put tens of billions of dollars in sales at risk between now and…
#BigPharma companies like BMS, J&J and Pfizer are facing #patentcliffs that will put tens of billions of dollars in sales at risk between now and…
Shared by Greg Slabodkin
-
A label expansion and traditional #FDA approval of Sarepta's Elevidys #genetherapy is an important milestone, but challenges still face the…
A label expansion and traditional #FDA approval of Sarepta's Elevidys #genetherapy is an important milestone, but challenges still face the…
Shared by Greg Slabodkin
-
#AI can take data from #biopsies to design #cancervaccines targeting patient-specific #mutations. Leveraging tumor/blood biopsy advances…
#AI can take data from #biopsies to design #cancervaccines targeting patient-specific #mutations. Leveraging tumor/blood biopsy advances…
Shared by Greg Slabodkin
-
#Genetictherapies could help fight #obesity, if early research pans out, with #weightloss similar to that achieved by #GLP1 drugs but without some…
#Genetictherapies could help fight #obesity, if early research pans out, with #weightloss similar to that achieved by #GLP1 drugs but without some…
Shared by Greg Slabodkin
-
With another anti-#amyloid antibody poised for #FDA approval, properly diagnosing #AlzheimersDisease has never been more urgent but the U.S. is…
With another anti-#amyloid antibody poised for #FDA approval, properly diagnosing #AlzheimersDisease has never been more urgent but the U.S. is…
Shared by Greg Slabodkin
-
Last week my mom Judee Axelsen, Ph.D. passed on after a nearly 15 year struggle with Alzheimer's Disease or dementia. She was many things, and always…
Last week my mom Judee Axelsen, Ph.D. passed on after a nearly 15 year struggle with Alzheimer's Disease or dementia. She was many things, and always…
Liked by Greg Slabodkin
-
While the #FDA has warned about the risk of #secondarycancers in patients receiving #CARTcelltherapy, results of a large Stanford Medicine…
While the #FDA has warned about the risk of #secondarycancers in patients receiving #CARTcelltherapy, results of a large Stanford Medicine…
Shared by Greg Slabodkin
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More